Forest Laboratories Receives Decision from FDA for Supplemental New Drug … – MarketWatch (press release)

posted on Feb 23 by in the Uncategorized category

Forest Laboratories Receives Decision from FDA for Supplemental New Drug ...
MarketWatch (press release)
Bystolic is currently approved in the US for the treatment of hypertension. However, FDA added information to the Specific Populations section of the ...

and more »

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes